Richard Ian Griffiths - 18 Dec 2024 SCHEDULE 13D/A Report for Silence Therapeutics Plc Ordinary Shares, nominal value of GBP0.05 per share (SLN)

Filing Manager: Richard Ian Griffiths
Reporting Manager: Richard Ian Griffiths
Security: Silence Therapeutics Plc Ordinary Shares, nominal value of GBP0.05 per share
Symbol: SLN
Shares outstanding: 141,274,617 shares
Disclosed Ownership: 27,266,001 shares
Ownership: 19%
Form type: SCHEDULE 13D/A
Filing time: 20 Dec 2024, 17:32:41 UTC
Date of event: 18 Dec 2024
Next filing: 31 Mar 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Richard Ian Griffiths	19%	27,266,001	27,266,001	0	/s/ Richard Ian Griffiths	Richard Ian Griffiths	0001846370
Ora Capital Limited	14%	19,221,525	19,221,525	0	/s/ Richard Ian Griffiths	Richard Ian Griffiths Director